GEP20135942B - Pharmaceutical comprising myramistin - Google Patents

Pharmaceutical comprising myramistin

Info

Publication number
GEP20135942B
GEP20135942B GEAP201112831A GEAP2011012831A GEP20135942B GE P20135942 B GEP20135942 B GE P20135942B GE AP201112831 A GEAP201112831 A GE AP201112831A GE AP2011012831 A GEAP2011012831 A GE AP2011012831A GE P20135942 B GEP20135942 B GE P20135942B
Authority
GE
Georgia
Prior art keywords
propyl
pharmaceutical
myristoylamino
myramistin
stoylamino
Prior art date
Application number
GEAP201112831A
Inventor
Adolina Rudko
Original Assignee
Megainpharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Megainpharm Gmbh filed Critical Megainpharm Gmbh
Publication of GEP20135942B publication Critical patent/GEP20135942B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

There is represented pharmaceutical containing benzyldimethyl-(3-[myristoylamino]propyl)ammo-nium chloride together with dimethyl-(3-[my¬ri¬stoylamino]propyl)ammonium oxide and/or dime¬thyl-[3-(myristoylamino)propyl]amine in pharmace¬uti¬cally appropriate solvent.
GEAP201112831A 2010-02-19 2011-02-15 Pharmaceutical comprising myramistin GEP20135942B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2010/001056 WO2011100994A1 (en) 2010-02-19 2010-02-19 Pharmaceutical comprising myramistin

Publications (1)

Publication Number Publication Date
GEP20135942B true GEP20135942B (en) 2013-10-10

Family

ID=42668884

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201112831A GEP20135942B (en) 2010-02-19 2011-02-15 Pharmaceutical comprising myramistin

Country Status (21)

Country Link
EP (1) EP2536400B1 (en)
JP (1) JP5746224B2 (en)
KR (1) KR101744895B1 (en)
CN (1) CN102869354B (en)
AU (1) AU2011217530B2 (en)
BR (1) BR112012020828B1 (en)
CY (1) CY1115833T1 (en)
DK (1) DK2536400T3 (en)
EA (1) EA022283B1 (en)
ES (1) ES2524379T3 (en)
GE (1) GEP20135942B (en)
HK (1) HK1179164A1 (en)
HR (1) HRP20141173T1 (en)
IL (1) IL221501A (en)
MD (1) MD4411C1 (en)
MX (1) MX2012009646A (en)
PL (1) PL2536400T3 (en)
PT (1) PT2536400E (en)
SI (1) SI2536400T1 (en)
UA (1) UA103968C2 (en)
WO (2) WO2011100994A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014175757A1 (en) * 2013-04-22 2014-10-30 Общество с ограниченной ответственностью "Нанобиотех" Antiseptic veterinary formulation and methods for use thereof
RU2542376C1 (en) * 2013-07-30 2015-02-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Agent for pyoinflammatory processes in soft tissues and mucous membranes
CN109456218A (en) * 2018-12-17 2019-03-12 山东诚汇双达药业有限公司 A kind of production method of trimecaine hydrochloride

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2459062A (en) 1944-02-08 1949-01-11 American Cyanamid Co Quaternary ammonium compounds
US4093711A (en) * 1976-08-13 1978-06-06 Noxell Corporation Oral hygiene
SU1796185A1 (en) 1990-06-23 1993-02-23 Adolina P Rudko Fungicide
WO1993000892A1 (en) 1991-07-10 1993-01-21 Jury Semenovich Krivoshein Pharmaceutical preparation
US5393491A (en) 1993-09-22 1995-02-28 Alcon Laboratories, Inc. Use of amidoamines in ophthalmic compositions
UA30143C2 (en) * 1997-12-30 2001-11-15 Юрій Семенович Кривошеін TREATMENT FOR PREVENTION AND TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES
RU2157214C2 (en) 1998-04-16 2000-10-10 Государственный научный центр лекарственных средств Anti-inflammatory and antibacterial drug for topical use
RU2161961C1 (en) 2000-03-17 2001-01-20 Кривошеин Юрий Семенович Therapeutic preparation
RU2177314C2 (en) 2000-03-22 2001-12-27 Кривошеин Юрий Семенович Composition eliciting antiseptic, reparative and analgetic properties
RU2173142C1 (en) 2000-04-18 2001-09-10 Кривошеин Юрий Семенович Vaginal contraceptive
RU2164135C1 (en) * 2000-04-27 2001-03-20 Рудько Адолина Петровна Ophthalmic antiseptic agent
RU2184534C2 (en) 2000-04-27 2002-07-10 Рудько Адолина Петровна Antiseptic tablets
RU2185156C2 (en) 2000-06-26 2002-07-20 Рудько Адолина Петровна Intranasal antiseptic
RU2185157C2 (en) 2000-06-26 2002-07-20 Рудько Адолина Петровна Composition for treating burn wounds
RU2188005C2 (en) 2000-10-04 2002-08-27 Рудько Адолина Петровна Composition for antiseptic treatment of hand skin and operation field
WO2002049633A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Use of amidoamines to treat or prevent acanthamoeba and fungal infections
US20040033208A1 (en) 2000-12-20 2004-02-19 Cagle Gerald D. Antifungal compositions containing an antibiotic and one or more amidoamines
AU2002226926A1 (en) * 2000-12-20 2002-07-01 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
RU2234313C1 (en) 2003-06-04 2004-08-20 Кривошеин Юрий Семенович Agent for inactivation of coronaviruses
RU2005100533A (en) * 2005-01-13 2006-06-20 Открытое акционерное общество "Система-Венчур" (ОАО "Система-Венчур") (RU) Means for accelerating wound healing
CN101562971A (en) * 2006-05-10 2009-10-21 S.K.药物公司 Synergistically enhanced disinfecting solutions
US20070264226A1 (en) 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
CN101100432B (en) * 2006-07-04 2010-08-04 中国人民解放军军事医学科学院毒物药物研究所 Method for synthesizing benzyldimethyl[3-(myristamide)propyl]ammonium chloride
DE102008039234A1 (en) * 2007-10-29 2009-05-07 Neudecker & Jolitz Gmbh & Co. Servo motor for door opener has a brake disc with mechanical brake to hold the door in the open position
UA30143U (en) 2007-11-14 2008-02-11 Валерий Михайлович Шарапов Piezoelectric transformer
DE102008039254A1 (en) * 2008-08-20 2010-02-25 Megainpharm Gmbh Medicament, useful e.g. for treating infectious- and purulent inflammatory diseases of e.g. eyes, comprises benzyl-dimethyl-(3-(myristoylamino)-propyl)-ammonium chloride, dimethyl-(3-(myristoylamino)-propyl)-amine oxide and solvent

Also Published As

Publication number Publication date
EP2536400A1 (en) 2012-12-26
HRP20141173T1 (en) 2015-01-30
SI2536400T1 (en) 2015-01-30
MX2012009646A (en) 2013-02-11
EP2536400B1 (en) 2014-09-24
KR101744895B1 (en) 2017-06-08
UA103968C2 (en) 2013-12-10
AU2011217530A1 (en) 2012-09-13
MD4411B1 (en) 2016-04-30
IL221501A (en) 2016-11-30
PL2536400T3 (en) 2015-04-30
CY1115833T1 (en) 2017-01-25
WO2011100994A1 (en) 2011-08-25
CN102869354B (en) 2015-12-16
KR20130018242A (en) 2013-02-20
AU2011217530B2 (en) 2014-01-16
CN102869354A (en) 2013-01-09
EA022283B1 (en) 2015-12-30
ES2524379T3 (en) 2014-12-05
JP2013519695A (en) 2013-05-30
MD20120079A2 (en) 2013-01-31
DK2536400T3 (en) 2014-12-15
BR112012020828B1 (en) 2021-01-12
JP5746224B2 (en) 2015-07-08
HK1179164A1 (en) 2013-09-27
BR112012020828A2 (en) 2016-06-28
PT2536400E (en) 2014-11-27
MD4411C1 (en) 2016-11-30
EA201201158A1 (en) 2013-02-28
WO2011101113A1 (en) 2011-08-25

Similar Documents

Publication Publication Date Title
ZA201607039B (en) Method for determining and comparing users' paths in a building
EP2616942A4 (en) Method and computing device for creating distinct user spaces
HK1204170A1 (en) Method and or system for user authentication with targeted electronic advertising content through personal communication devices
GB2483973B (en) Facial make-up application machine and make-up application method using the same
EP2291759A4 (en) Interconnectable personal computer architectures that provide secure, portable and persistent computing environments
BR112014032092A2 (en) display apparatus, and method for providing response information for providing appropriate response information to a user's voice in a display apparatus.
FI3246070T3 (en) Novel fxr (nr1h4) binding and activity modulating azoles
EP2627358C0 (en) Pretargeting kit, method and agents used therein
GB201216907D0 (en) Virtual fare card and virtual fare device
EP2767136A4 (en) User terminal device and content sharing method thereof
EP2166481A4 (en) User authentication device, user authentication method, and user authentication program
EP2792105A4 (en) User authentication and authorization using personas
EP2180424A4 (en) User authentication device, user authentication method, and user authentication program
EP2316935A4 (en) Aptamer against il-17 and use thereof
BRPI0816934A2 (en) FACIAL AND MUCULAR MUSCULATURE STIMULATOR
EP2656291A4 (en) User identity attestation in mobile commerce
EP2302875A4 (en) Portable device, display method, and display program
IL214244A0 (en) Scriptaid isosteres and their use in therapy
EG26444A (en) Systems and methods for computing and validating avariogram model
HK1182811A1 (en) Recommending data based on user and data attributes
EP2339499A4 (en) Storage device, information processing device, and program
GEP20135942B (en) Pharmaceutical comprising myramistin
EP2867796A4 (en) User events/behaviors and perceptual computing system emulation
SG11201404413UA (en) A composition and use thereof in the treatment of anal rhagades
FR2939825B1 (en) POST WITH DOUBLE THROUGH GRIP AND CLOSURE COMPRISING SUCH A POST